 | • レポートコード：MRCLP3DB2111 • 出版社/出版日：LP Information / 2023年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーション社の最新調査レポート「ポリペプチド老化防止剤の世界市場」は、過去の販売実績から2022年の世界のポリペプチド老化防止剤の総販売量を検討し、2023年から2029年の予測されるポリペプチド老化防止剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のポリペプチド老化防止剤の市場規模を掲載し、XXX百万米ドル規模の世界のポリペプチド老化防止剤市場の詳細な分析を提供します。本インサイトレポートは、世界のポリペプチド老化防止剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界のポリペプチド老化防止剤市場における各社の独自のポジションをより深く理解するために、ポリペプチド老化防止剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界のポリペプチド老化防止剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ポリペプチド老化防止剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ポリペプチド老化防止剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ポリペプチド老化防止剤の欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 ポリペプチド老化防止剤の世界主要メーカーとしては、Evonik、 Uniproma Chemical、 A&PEP、 Active Concepts、 Ashland、 BASF、 Bio-nest、 CORUM、 Cobiosa、 Croda、 DSM、 Givaudan、 Caregen、 Lubrizol、 Incospharm、 Lucas Meyer Cosmetics、 MakingCosmetics、 Mibelle Biochemistry、 Miwon Commercial、 NUWEN、 SEIWA KASEI、 PnP Biopharm Co., Ltd、 Vantage、 aurorium、 Spec-Chem Industry、 Fenchem、 Angel Yeastなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別のポリペプチド老化防止剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査ではポリペプチド老化防止剤市場をセグメンテーションし、種類別 (トリペプチド、テトラペプチド、ペンタペプチド、ヘキサペプチド、その他)、用途別 (クリーム、エッセンス、アイクリーム、フェイシャルマスク、その他)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：トリペプチド、テトラペプチド、ペンタペプチド、ヘキサペプチド、その他 ・用途別区分：クリーム、エッセンス、アイクリーム、フェイシャルマスク、その他 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界のポリペプチド老化防止剤市場の10年間の市場状況・展望は？ ・世界および地域別に見たポリペプチド老化防止剤市場成長の要因は何か？ ・ポリペプチド老化防止剤の市場機会はエンドマーケットの規模によってどのように変化するのか？ ・ポリペプチド老化防止剤のタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：ポリペプチド老化防止剤の年間販売量2018-2029、地域別現状・将来分析 ・ポリペプチド老化防止剤の種類別セグメント：トリペプチド、テトラペプチド、ペンタペプチド、ヘキサペプチド、その他 ・ポリペプチド老化防止剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・ポリペプチド老化防止剤の用途別セグメント：クリーム、エッセンス、アイクリーム、フェイシャルマスク、その他 ・ポリペプチド老化防止剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界のポリペプチド老化防止剤市場 ・企業別のグローバルポリペプチド老化防止剤市場データ：2018-2023年の年間販売量、市場シェア ・企業別のポリペプチド老化防止剤の年間売上：2018-2023年の売上、市場シェア ・企業別のポリペプチド老化防止剤販売価格 ・主要企業のポリペプチド老化防止剤生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 ポリペプチド老化防止剤の地域別レビュー ・地域別のポリペプチド老化防止剤市場規模2018-2023：年間販売量、売上 ・主要国別のポリペプチド老化防止剤市場規模2018-2023：年間販売量、売上 ・南北アメリカのポリペプチド老化防止剤販売の成長 ・アジア太平洋のポリペプチド老化防止剤販売の成長 ・欧州のポリペプチド老化防止剤販売の成長 ・中東・アフリカのポリペプチド老化防止剤販売の成長 南北アメリカ市場 ・南北アメリカの国別のポリペプチド老化防止剤販売量、売上（2018-2023） ・南北アメリカのポリペプチド老化防止剤の種類別販売量 ・南北アメリカのポリペプチド老化防止剤の用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別のポリペプチド老化防止剤販売量、売上（2018-2023） ・アジア太平洋のポリペプチド老化防止剤の種類別販売量 ・アジア太平洋のポリペプチド老化防止剤の用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別のポリペプチド老化防止剤販売量、売上（2018-2023） ・欧州のポリペプチド老化防止剤の種類別販売量 ・欧州のポリペプチド老化防止剤の用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別のポリペプチド老化防止剤販売量、売上（2018-2023） ・中東・アフリカのポリペプチド老化防止剤の種類別販売量 ・中東・アフリカのポリペプチド老化防止剤の用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・ポリペプチド老化防止剤の製造コスト構造分析 ・ポリペプチド老化防止剤の製造プロセス分析 ・ポリペプチド老化防止剤の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・ポリペプチド老化防止剤の主要なグローバル販売業者 ・ポリペプチド老化防止剤の主要なグローバル顧客 地域別のポリペプチド老化防止剤市場予測レビュー ・地域別のポリペプチド老化防止剤市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・ポリペプチド老化防止剤の種類別市場規模予測 ・ポリペプチド老化防止剤の用途別市場規模予測 主要企業分析 Evonik、 Uniproma Chemical、 A&PEP、 Active Concepts、 Ashland、 BASF、 Bio-nest、 CORUM、 Cobiosa、 Croda、 DSM、 Givaudan、 Caregen、 Lubrizol、 Incospharm、 Lucas Meyer Cosmetics、 MakingCosmetics、 Mibelle Biochemistry、 Miwon Commercial、 NUWEN、 SEIWA KASEI、 PnP Biopharm Co., Ltd、 Vantage、 aurorium、 Spec-Chem Industry、 Fenchem、 Angel Yeast ・企業情報 ・ポリペプチド老化防止剤製品 ・ポリペプチド老化防止剤販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Polypeptide Anti-aging Agent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Polypeptide Anti-aging Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Polypeptide Anti-aging Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Polypeptide Anti-aging Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Polypeptide Anti-aging Agent players cover Evonik, Uniproma Chemical, A&PEP, Active Concepts, Ashland, BASF, Bio-nest, CORUM and Cobiosa, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Polypeptide anti-aging agents are a class of compounds used in the field of skin care and health, and they are composed of multiple amino acid residues. Polypeptides are the building blocks of proteins and have multiple functions and biological activities. In the field of anti-aging, peptides are widely used in skin care products to improve skin texture, reduce wrinkles, improve skin elasticity, etc.
LPI (LP Information)’ newest research report, the “Polypeptide Anti-aging Agent Industry Forecast” looks at past sales and reviews total world Polypeptide Anti-aging Agent sales in 2022, providing a comprehensive analysis by region and market sector of projected Polypeptide Anti-aging Agent sales for 2023 through 2029. With Polypeptide Anti-aging Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polypeptide Anti-aging Agent industry.
This Insight Report provides a comprehensive analysis of the global Polypeptide Anti-aging Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polypeptide Anti-aging Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polypeptide Anti-aging Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polypeptide Anti-aging Agent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polypeptide Anti-aging Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of Polypeptide Anti-aging Agent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tripeptide
Tetrapeptide
Pentapeptide
Hexapeptide
Other
Segmentation by application
Cream
Essence
Eye Cream
Facial Mask
Othe
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Evonik
Uniproma Chemical
A&PEP
Active Concepts
Ashland
BASF
Bio-nest
CORUM
Cobiosa
Croda
DSM
Givaudan
Caregen
Lubrizol
Incospharm
Lucas Meyer Cosmetics
MakingCosmetics
Mibelle Biochemistry
Miwon Commercial
NUWEN
SEIWA KASEI
PnP Biopharm Co., Ltd
Vantage
aurorium
Spec-Chem Industry
Fenchem
Angel Yeast
Key Questions Addressed in this Report
What is the 10-year outlook for the global Polypeptide Anti-aging Agent market?
What factors are driving Polypeptide Anti-aging Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Polypeptide Anti-aging Agent market opportunities vary by end market size?
How does Polypeptide Anti-aging Agent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polypeptide Anti-aging Agent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Polypeptide Anti-aging Agent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Polypeptide Anti-aging Agent by Country/Region, 2018, 2022 & 2029
2.2 Polypeptide Anti-aging Agent Segment by Type
2.2.1 Tripeptide
2.2.2 Tetrapeptide
2.2.3 Pentapeptide
2.2.4 Hexapeptide
2.2.5 Other
2.3 Polypeptide Anti-aging Agent Sales by Type
2.3.1 Global Polypeptide Anti-aging Agent Sales Market Share by Type (2018-2023)
2.3.2 Global Polypeptide Anti-aging Agent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Polypeptide Anti-aging Agent Sale Price by Type (2018-2023)
2.4 Polypeptide Anti-aging Agent Segment by Application
2.4.1 Cream
2.4.2 Essence
2.4.3 Eye Cream
2.4.4 Facial Mask
2.4.5 Othe
2.5 Polypeptide Anti-aging Agent Sales by Application
2.5.1 Global Polypeptide Anti-aging Agent Sale Market Share by Application (2018-2023)
2.5.2 Global Polypeptide Anti-aging Agent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Polypeptide Anti-aging Agent Sale Price by Application (2018-2023)
3 Global Polypeptide Anti-aging Agent by Company
3.1 Global Polypeptide Anti-aging Agent Breakdown Data by Company
3.1.1 Global Polypeptide Anti-aging Agent Annual Sales by Company (2018-2023)
3.1.2 Global Polypeptide Anti-aging Agent Sales Market Share by Company (2018-2023)
3.2 Global Polypeptide Anti-aging Agent Annual Revenue by Company (2018-2023)
3.2.1 Global Polypeptide Anti-aging Agent Revenue by Company (2018-2023)
3.2.2 Global Polypeptide Anti-aging Agent Revenue Market Share by Company (2018-2023)
3.3 Global Polypeptide Anti-aging Agent Sale Price by Company
3.4 Key Manufacturers Polypeptide Anti-aging Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polypeptide Anti-aging Agent Product Location Distribution
3.4.2 Players Polypeptide Anti-aging Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Polypeptide Anti-aging Agent by Geographic Region
4.1 World Historic Polypeptide Anti-aging Agent Market Size by Geographic Region (2018-2023)
4.1.1 Global Polypeptide Anti-aging Agent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Polypeptide Anti-aging Agent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Polypeptide Anti-aging Agent Market Size by Country/Region (2018-2023)
4.2.1 Global Polypeptide Anti-aging Agent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Polypeptide Anti-aging Agent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Polypeptide Anti-aging Agent Sales Growth
4.4 APAC Polypeptide Anti-aging Agent Sales Growth
4.5 Europe Polypeptide Anti-aging Agent Sales Growth
4.6 Middle East & Africa Polypeptide Anti-aging Agent Sales Growth
5 Americas
5.1 Americas Polypeptide Anti-aging Agent Sales by Country
5.1.1 Americas Polypeptide Anti-aging Agent Sales by Country (2018-2023)
5.1.2 Americas Polypeptide Anti-aging Agent Revenue by Country (2018-2023)
5.2 Americas Polypeptide Anti-aging Agent Sales by Type
5.3 Americas Polypeptide Anti-aging Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polypeptide Anti-aging Agent Sales by Region
6.1.1 APAC Polypeptide Anti-aging Agent Sales by Region (2018-2023)
6.1.2 APAC Polypeptide Anti-aging Agent Revenue by Region (2018-2023)
6.2 APAC Polypeptide Anti-aging Agent Sales by Type
6.3 APAC Polypeptide Anti-aging Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Polypeptide Anti-aging Agent by Country
7.1.1 Europe Polypeptide Anti-aging Agent Sales by Country (2018-2023)
7.1.2 Europe Polypeptide Anti-aging Agent Revenue by Country (2018-2023)
7.2 Europe Polypeptide Anti-aging Agent Sales by Type
7.3 Europe Polypeptide Anti-aging Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Polypeptide Anti-aging Agent by Country
8.1.1 Middle East & Africa Polypeptide Anti-aging Agent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Polypeptide Anti-aging Agent Revenue by Country (2018-2023)
8.2 Middle East & Africa Polypeptide Anti-aging Agent Sales by Type
8.3 Middle East & Africa Polypeptide Anti-aging Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polypeptide Anti-aging Agent
10.3 Manufacturing Process Analysis of Polypeptide Anti-aging Agent
10.4 Industry Chain Structure of Polypeptide Anti-aging Agent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polypeptide Anti-aging Agent Distributors
11.3 Polypeptide Anti-aging Agent Customer
12 World Forecast Review for Polypeptide Anti-aging Agent by Geographic Region
12.1 Global Polypeptide Anti-aging Agent Market Size Forecast by Region
12.1.1 Global Polypeptide Anti-aging Agent Forecast by Region (2024-2029)
12.1.2 Global Polypeptide Anti-aging Agent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polypeptide Anti-aging Agent Forecast by Type
12.7 Global Polypeptide Anti-aging Agent Forecast by Application
13 Key Players Analysis
13.1 Evonik
13.1.1 Evonik Company Information
13.1.2 Evonik Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.1.3 Evonik Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Evonik Main Business Overview
13.1.5 Evonik Latest Developments
13.2 Uniproma Chemical
13.2.1 Uniproma Chemical Company Information
13.2.2 Uniproma Chemical Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.2.3 Uniproma Chemical Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Uniproma Chemical Main Business Overview
13.2.5 Uniproma Chemical Latest Developments
13.3 A&PEP
13.3.1 A&PEP Company Information
13.3.2 A&PEP Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.3.3 A&PEP Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 A&PEP Main Business Overview
13.3.5 A&PEP Latest Developments
13.4 Active Concepts
13.4.1 Active Concepts Company Information
13.4.2 Active Concepts Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.4.3 Active Concepts Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Active Concepts Main Business Overview
13.4.5 Active Concepts Latest Developments
13.5 Ashland
13.5.1 Ashland Company Information
13.5.2 Ashland Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.5.3 Ashland Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ashland Main Business Overview
13.5.5 Ashland Latest Developments
13.6 BASF
13.6.1 BASF Company Information
13.6.2 BASF Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.6.3 BASF Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BASF Main Business Overview
13.6.5 BASF Latest Developments
13.7 Bio-nest
13.7.1 Bio-nest Company Information
13.7.2 Bio-nest Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.7.3 Bio-nest Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bio-nest Main Business Overview
13.7.5 Bio-nest Latest Developments
13.8 CORUM
13.8.1 CORUM Company Information
13.8.2 CORUM Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.8.3 CORUM Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CORUM Main Business Overview
13.8.5 CORUM Latest Developments
13.9 Cobiosa
13.9.1 Cobiosa Company Information
13.9.2 Cobiosa Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.9.3 Cobiosa Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cobiosa Main Business Overview
13.9.5 Cobiosa Latest Developments
13.10 Croda
13.10.1 Croda Company Information
13.10.2 Croda Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.10.3 Croda Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Croda Main Business Overview
13.10.5 Croda Latest Developments
13.11 DSM
13.11.1 DSM Company Information
13.11.2 DSM Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.11.3 DSM Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 DSM Main Business Overview
13.11.5 DSM Latest Developments
13.12 Givaudan
13.12.1 Givaudan Company Information
13.12.2 Givaudan Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.12.3 Givaudan Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Givaudan Main Business Overview
13.12.5 Givaudan Latest Developments
13.13 Caregen
13.13.1 Caregen Company Information
13.13.2 Caregen Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.13.3 Caregen Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Caregen Main Business Overview
13.13.5 Caregen Latest Developments
13.14 Lubrizol
13.14.1 Lubrizol Company Information
13.14.2 Lubrizol Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.14.3 Lubrizol Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Lubrizol Main Business Overview
13.14.5 Lubrizol Latest Developments
13.15 Incospharm
13.15.1 Incospharm Company Information
13.15.2 Incospharm Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.15.3 Incospharm Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Incospharm Main Business Overview
13.15.5 Incospharm Latest Developments
13.16 Lucas Meyer Cosmetics
13.16.1 Lucas Meyer Cosmetics Company Information
13.16.2 Lucas Meyer Cosmetics Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.16.3 Lucas Meyer Cosmetics Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Lucas Meyer Cosmetics Main Business Overview
13.16.5 Lucas Meyer Cosmetics Latest Developments
13.17 MakingCosmetics
13.17.1 MakingCosmetics Company Information
13.17.2 MakingCosmetics Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.17.3 MakingCosmetics Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 MakingCosmetics Main Business Overview
13.17.5 MakingCosmetics Latest Developments
13.18 Mibelle Biochemistry
13.18.1 Mibelle Biochemistry Company Information
13.18.2 Mibelle Biochemistry Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.18.3 Mibelle Biochemistry Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mibelle Biochemistry Main Business Overview
13.18.5 Mibelle Biochemistry Latest Developments
13.19 Miwon Commercial
13.19.1 Miwon Commercial Company Information
13.19.2 Miwon Commercial Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.19.3 Miwon Commercial Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Miwon Commercial Main Business Overview
13.19.5 Miwon Commercial Latest Developments
13.20 NUWEN
13.20.1 NUWEN Company Information
13.20.2 NUWEN Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.20.3 NUWEN Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 NUWEN Main Business Overview
13.20.5 NUWEN Latest Developments
13.21 SEIWA KASEI
13.21.1 SEIWA KASEI Company Information
13.21.2 SEIWA KASEI Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.21.3 SEIWA KASEI Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 SEIWA KASEI Main Business Overview
13.21.5 SEIWA KASEI Latest Developments
13.22 PnP Biopharm Co., Ltd
13.22.1 PnP Biopharm Co., Ltd Company Information
13.22.2 PnP Biopharm Co., Ltd Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.22.3 PnP Biopharm Co., Ltd Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 PnP Biopharm Co., Ltd Main Business Overview
13.22.5 PnP Biopharm Co., Ltd Latest Developments
13.23 Vantage
13.23.1 Vantage Company Information
13.23.2 Vantage Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.23.3 Vantage Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Vantage Main Business Overview
13.23.5 Vantage Latest Developments
13.24 aurorium
13.24.1 aurorium Company Information
13.24.2 aurorium Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.24.3 aurorium Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 aurorium Main Business Overview
13.24.5 aurorium Latest Developments
13.25 Spec-Chem Industry
13.25.1 Spec-Chem Industry Company Information
13.25.2 Spec-Chem Industry Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.25.3 Spec-Chem Industry Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Spec-Chem Industry Main Business Overview
13.25.5 Spec-Chem Industry Latest Developments
13.26 Fenchem
13.26.1 Fenchem Company Information
13.26.2 Fenchem Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.26.3 Fenchem Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 Fenchem Main Business Overview
13.26.5 Fenchem Latest Developments
13.27 Angel Yeast
13.27.1 Angel Yeast Company Information
13.27.2 Angel Yeast Polypeptide Anti-aging Agent Product Portfolios and Specifications
13.27.3 Angel Yeast Polypeptide Anti-aging Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.27.4 Angel Yeast Main Business Overview
13.27.5 Angel Yeast Latest Developments
14 Research Findings and Conclusion